Richard J. Whitley

W. Michael Scheld

Christina M. Marra

The "gold standard" clinical reference on central nervous system infections is now in its thoroughly revised, updated Third Edition. More than 70 leading experts provide comprehensive, current information on all infections—both neural-specific and systemic—that involve the central nervous system. This edition includes new information on botulinum toxin as a biological weapon and a therapeutic agent, neurologic effects of viruses causing hemorrhagic fevers, and infections that have recently become more prevalent or been found in new geographic locations. The updated coverage of therapeutics includes AIDS/HIV medications and other antiviral drugs, new antifungal medications, and vaccinations against Lyme disease and bacterial meningitis.

Infections of the Central Nervous System

James M. Hughes

Scott Hammer

This new volume in the series is based on ICAAC and IDSA Symposia on Emerging Infections. It offers an updated review of new and emerging pathogens and infectious diseases, including novel non-SARS coronaviruses, community-associated methicillin-resistant Staphylococcus aureus, pertussis, extensively drug-resistant tuberculosis, and many others.

Emerging Infections 8

David T. Durack

Written by over 40 specialists, this aims to provide comprehensive coverage of all aspects of CNS infections, ranging from molecular pathogenesis to diagnosis, therapy and prevention. Ten sections cover viral, bacterial, fungal, protozoal infections and those caused by rarer pathogens etc.

Essential resource for the fight against emerging infectious diseases Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies. The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, Emerging Infections 10 explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities. Emerging Infections 10 presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

W. Michael Scheld

About

Books

Join the club